CMR and adverse clinical outcomes in peripartum cardiomyopathy
Agnes Koczo(University of Pittsburgh Medical Center), Timothy C. Wong(University of Pittsburgh Medical Center), Uri Elkayam(University of Southern California), Dennis M. McNamara(University of Pittsburgh Medical Center), Erik B. Schelbert(University of Pittsburgh Medical Center), Michael M. Givertz(Brigham and Women's Hospital), Rami Alharethi(Intermountain Medical Center), Deeksha Acharya(University of Pittsburgh Medical Center), Benay Özbay(University of Pittsburgh)
American Heart Journal Plus Cardiology Research and Practice
November 9, 2024
Cited by 1
Related Papers
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
|Journal of Cardiovascular Magnetic Resonance|2013|1.1k
Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure
|New England Journal of Medicine|2000|908
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction
|Circulation|2019|427
Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study
|American Heart Journal|2002|323
Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure
|Journal of the American College of Cardiology|2002|232